{"id":"https://genegraph.clinicalgenome.org/r/470c3869-ebaf-4234-b483-e21b17fe7f48v1.0","type":"EvidenceStrengthAssertion","dc:description":"","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/470c3869-ebaf-4234-b483-e21b17fe7f48","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2018-02-12T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10010","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70de764f-174c-4f07-9f72-3ce2b0c5b336_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c7db5b7-a6bf-4af7-89cc-5254f11f3cb3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 15","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"PCR-RFLP method, described by Ijlst et al","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/70de764f-174c-4f07-9f72-3ce2b0c5b336_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000182.4(HADHA):c.1528G>C (p.Glu510Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/100085"}},{"id":"https://genegraph.clinicalgenome.org/r/efd2dab8-b7bb-459a-bb96-f676a39389a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.26236903A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346094334"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6fe0b168-d117-49d8-aff2-748c96fa1231_proband_score_evidence_line","type":"EvidenceLine","dc:description":"LCHAD and long-chain 3-ketoacyl-CoA thiolase activities were measured in skin fibroblasts isolated from patients. See Table 1.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/619d4375-c465-40f0-8552-dea376cff51e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9739053","rdfs:label":"Proband A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"Direct sequencing of exonic fragments amplified from both genomic DNA or synthesized cDNA was performed using the appropriate sense or antisense primer, Allele-specific oligonucleotide (ASO) hybridization, Single-stranded conformation variance (SSCV) analysis of the a-subunit.","phenotypeFreeText":"Chronic progressive polyneuropathy and myopathy without hepatic or cardiac involvement","phenotypes":"obo:HP_0001271","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6fe0b168-d117-49d8-aff2-748c96fa1231_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9739053","allele":{"id":"https://genegraph.clinicalgenome.org/r/18bf3749-20e8-4332-bec7-5101e1ba88c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000182.4(HADHA):c.845T>A (p.Val282Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8735"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/eb594c21-c091-4271-ac30-8236fd3006be_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4853ab7f-326b-4e4a-92e0-25c9efe7364c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 28","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"detectionMethod":"PCR-RFLP method, described by Ijlst et al","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/eb594c21-c091-4271-ac30-8236fd3006be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"},{"id":"https://genegraph.clinicalgenome.org/r/3198e45c-7a51-422f-a307-2c6c9808ef3a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.26215089_26215092del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA531378705"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d05a5504-c71a-401e-9387-3d2ffe0240fd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Unclear if in cis or trans.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef4369ef-9b10-4f05-9ce9-80998e319b95","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9739053","rdfs:label":"Proband B","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"detectionMethod":"Direct sequencing of exonic fragments amplified from both genomic DNA or synthesized cDNA was performed using the appropriate sense or antisense primer, Allele-specific oligonucleotide (ASO) hybridization, Single-stranded conformation variance (SSCV) analysis of the a-subunit","phenotypeFreeText":"Muscle weakness, myglobinuria, slow progressive sensorimotor polyneuropathy, bilateral foot drop, contracture of Achilles tendons","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d05a5504-c71a-401e-9387-3d2ffe0240fd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9739053","allele":[{"id":"https://genegraph.clinicalgenome.org/r/21909361-0da7-4ed8-a9ea-d9fab3d6c927","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000182.4(HADHA):c.871C>T (p.Arg291Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8737"}},{"id":"https://genegraph.clinicalgenome.org/r/26caffb6-f2b8-485f-bacd-8be23b6b8c6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000182.4(HADHA):c.914T>A (p.Ile305Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8736"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/51c876a1-7f0e-4b02-bbcd-534a0f74c3d9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"One unique phenotype associated with LCHAD deficiency is the development\nof HELLP syndrome and AFLP in women who carry LCHAD-deficient fetuses\n(Sims et al 1995; Wilcken et al 1993).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b2f0114-b048-4271-a9b8-d35e9c94c5d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10518281","rdfs:label":"Ibdah 1999 Proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"detectionMethod":"Single-strand conformational variance (SSCV) analysis and direct sequencing.","phenotypeFreeText":"Elevated intact parathyroid hormone level, low 25-hydroxyvitamin D, elevated c-glutamyltransferase","phenotypes":["obo:HP_0003155","obo:HP_0001396","obo:HP_0002069","obo:HP_0002901"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/51c876a1-7f0e-4b02-bbcd-534a0f74c3d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10518281","allele":{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/74e2cf41-3179-4088-b902-8f2841c1912b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b279d31-facf-42f9-af09-0281e787ac32","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"detectionMethod":"PCR-RFLP method, described by Ijlst et al. Amplification of the coding sequence of the HADHA gene was always started from exon 15, where the common mutation is localized","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/74e2cf41-3179-4088-b902-8f2841c1912b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4858de0b-0ce6-4efa-a340-a40a56a52a73_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/357c12dd-7c96-49dd-9e9f-0570a7de1a86","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 10","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"detectionMethod":"PCR-RFLP method, described by Ijlst et al","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4858de0b-0ce6-4efa-a340-a40a56a52a73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":[{"id":"https://genegraph.clinicalgenome.org/r/3198e45c-7a51-422f-a307-2c6c9808ef3a"},{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/75990180-a5cc-4a47-a072-70a4a65e5d30_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed8c4fe4-2874-47ec-9d71-db87c509a5ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 26","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":7,"detectionMethod":"PCR-RFLP method, described by Ijlst et al","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/75990180-a5cc-4a47-a072-70a4a65e5d30_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"},{"id":"https://genegraph.clinicalgenome.org/r/84ed4c54-e245-4052-9cd0-f137bf8d207b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000182.4(HADHA):c.2107G>A (p.Gly703Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/429439"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ec71e0d7-3a9e-4b45-8a0e-4fbd55d95a4b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/731af019-6052-4518-a13e-d20e91777e54","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"detectionMethod":"PCR-RFLP method, described by Ijlst et al. Amplification of the coding sequence of the HADHA gene was always started from exon 15, where the common mutation is localized","phenotypeFreeText":"The study group included 44 patients diagnosed by metabolic testing after the disease symptoms appeared","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec71e0d7-3a9e-4b45-8a0e-4fbd55d95a4b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21103935","allele":{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b1d87330-9eb0-4c71-8d10-a4fb611cc685_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is found in approximately 87% of the chromosomes in patients with LCHADD. Expression of this variant in yeast results in no enzyme activity (IJlst et al. 1996).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/036e6729-3180-4f39-8035-bcf182c12b4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7811722","rdfs:label":"Ijlst 1994 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequenced the cDNAs encoding the alpha- and beta-subunits","phenotypeFreeText":"Molecular diagnosis of LCHADD","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b1d87330-9eb0-4c71-8d10-a4fb611cc685_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7811722","allele":{"id":"https://genegraph.clinicalgenome.org/r/b436fe02-da4c-4bcb-b0f7-e6795faa60e9"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.5},{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86370307-39b6-485a-aa1f-1d87505b5304","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2ddd768-e78b-4dbc-9b57-84c832ebec2c","type":"Finding","dc:description":"Accumulation of long chain fatty acid metabolites in Mtpa-/- fetuses and low birth weight compared with the Mtpa+/– and Mtpa+/+ littermates. Neonatal hypoglycemia and sudden death 6–36 hours after birth. Rapid development of hepatic steatosis after birth and, later, significant necrosis and acute degeneration of the cardiac and diaphragmatic myocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11390422","rdfs:label":"Ibdah 2001 Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c8a5e15b-21f7-49cc-987c-5f3585742bbe_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a96ddc0-05d0-4414-a017-0e222e12ba8f","type":"EvidenceLine","dc:description":"Possible that the reduction in activity could be due to something else in the patient.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0693b103-319e-436b-bfec-8210b68375f8","type":"FunctionalAlteration","dc:description":"The long-chain enoyl-CoA hydratase and long-chain 3-ketoacyl-CoA thiolase activities was same whereas long-chain 3-hydroxyacyl-CoA dehydrogenase activity was significantly reduced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8770876","rdfs:label":"Ijlst 1996 Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":56,"specifiedBy":"GeneValidityCriteria6","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/v4AR_eQIn9w","type":"GeneValidityProposition","disease":"obo:MONDO_0012173","gene":"hgnc:4801","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c8a5e15b-21f7-49cc-987c-5f3585742bbe-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}